Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population
NCT00847834
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
968
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Irbesartan 150mg / Hydrochlorothiazide 12.5mg
DRUG:
Irbesartan 150mg
Sponsor
Sanofi